Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Johnson & Johnson
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Number of employees : 134 500 people.
Sales per Business
20192020Delta
Pharmaceutical42 198.0051.4%45 572.0055.2% +8%
Medical Devices25 963.0031.6%22 959.0027.8% -11.57%
Consumer13 898.0016.9%14 053.0017% +1.12%
USD in Million
Sales per region
20192020Delta
United States42 097.0051.3%43 133.0052.2% +2.46%
Europe18 466.0022.5%18 980.0023% +2.78%
Asia-Pacific, Africa15 555.0018.9%15 136.0018.3% -2.69%
Western Hemisphere Excluding United States5 941.007.2%5 335.006.5% -10.2%
USD in Million
Managers
Name Title Age Since
Alex Gorsky Chairman & Chief Executive Officer 59 2012
Joseph Wolk Chief Financial Officer & Executive Vice President 53 2018
Paulus Stoffels Chief Scientific Officer 59 2012
James Swanson Global Chief Information Officer & Executive VP - 2019
Charles O. Prince Independent Director 70 2006
Anne M. Mulcahy Lead Independent Director 67 2012
Ronald Williams Independent Director 70 2011
Ian Davis Independent Director 69 2010
A. Eugene Washington, Dr. Independent Director 69 2012
Mark B. McClellan, Dr. Independent Director 56 2013
Members of the board
Name Title Age Since
Alex Gorsky Chairman & Chief Executive Officer 59 2012
Charles O. Prince Independent Director 70 2006
Anne M. Mulcahy Lead Independent Director 67 2012
Ronald Williams Independent Director 70 2011
Ian Davis Independent Director 69 2010
A. Eugene Washington, Dr. Independent Director 69 2012
Mark B. McClellan, Dr. Independent Director 56 2013
D. Davis Independent Director 68 2014
Mary C. Beckerle, Dr. Independent Director 65 2015
Jennifer A. Doudna, Dr. Independent Director 56 2018
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,120,537,003 2,631,210,582 84.3% 487,141,000 15.6% 84.3%
Shareholders
NameEquities%
The Vanguard Group, Inc. 218,494,118 8.30%
SSgA Funds Management, Inc. 140,270,595 5.33%
BlackRock Fund Advisors 61,026,749 2.32%
Geode Capital Management LLC 40,825,241 1.55%
State Farm Investment Management Corp. 34,574,792 1.31%
Wellington Management Co. LLP 33,886,162 1.29%
Capital Research & Management Co. 32,520,000 1.23%
Northern Trust Investments, Inc.(Investment Management) 32,058,041 1.22%
Massachusetts Financial Services Co. 27,864,699 1.06%
Norges Bank Investment Management 27,770,786 1.05%
Holdings
NameEquities%Valuation
ADIMMUNE CORPORATION (4142) 18,715,000 4.36% 35,457,065 USD
CRYO-CELL INTERNATIONAL, INC. (CCEL) 152,724 1.91% 1,336,335 USD
GRAIL, INC. 50,868,671 7.58% 509 USD
IDORSIA LTD (IDIA) 0 0.0000%
Markets and indexes
- International Market
- DJIA / S&P 100, S&P 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Company contact information
Johnson & Johnson
1 Plaza Johnson et Johnson
NJ 08933 New Brunswick, New Jersey

Phone : +1 (732) 524 0400
Fax :
web site : http://www.jnj.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Johnson & Johnson
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
JOHNSON & JOHNSON9.16%432 430
ROCHE HOLDING AG12.39%325 975
PFIZER, INC.13.23%218 198
ELI LILLY AND COMPANY44.60%209 276
NOVARTIS AG1.10%207 246
ABBVIE INC.10.30%199 548
MERCK & CO., INC.-5.21%195 475
NOVO NORDISK A/S33.81%188 446
ASTRAZENECA PLC15.78%155 197
BRISTOL-MYERS SQUIBB COMPANY10.17%149 020
AMGEN INC.7.74%139 433
SANOFI11.91%131 827
GLAXOSMITHKLINE PLC5.51%98 364
JIANGSU HENGRUI MEDICINE CO., LTD.-33.80%67 158
CHUGAI PHARMACEUTICAL CO., LTD.-25.00%65 930
ALLERGAN PLC0.97%63 659
BAYER AG6.32%60 766
TAKEDA PHARMACEUTICAL COMPANY LIMITED-1.20%53 101
DAIICHI SANKYO COMPANY, LIMITED-37.04%42 298
ASTELLAS PHARMA INC.19.95%33 619
EISAI CO., LTD.24.00%30 450